| Literature DB >> 26691475 |
Martín Marchisio1, Ayelén Porto1, Romina Joris1, Marina Rico1, María R Baroni1, José Di Conza1.
Abstract
The antibiotic susceptibility profile was evaluated in 71 Enterobacteriaceae isolates obtained from outpatient urine cultures in July 2010 from two health institutions in Santa Fe, Argentina. The highest rates of antibiotic resistance were observed for ampicillin (AMP) (69%), trimethoprim/sulfamethoxazole (TMS) (33%), and ciprofloxacin (CIP) (25%). Meanwhile, 21% of the isolates were resistant to three or more tested antibiotics families. Thirty integron-containing bacteria (42.3%) were detected, and a strong association with TMS resistance was found. Third generation cephalosporin resistance was detected in only one Escherichia coli isolate, and it was characterized as a blaCMY-2 carrier. No plasmid-mediated quinolone resistance (PMQR) was found. Resistance to fluoroquinolone in the isolates was due to alterations in QRDR regions. Two mutations in GyrA (S83L, D87N) and one in ParC (S80I) were observed in all CIP-resistant E. coli. It was determined to be the main phylogenetic groups in E. coli isolates. Minimum Inhibitory Concentration (MIC) values against nalidixic acid (NAL), levofloxacin (LEV), and CIP were determined for 63 uropathogenic E. coli isolates as MIC50 of 4 μg/mL, 0.03125 μg/mL, and 0.03125 μg/mL, respectively, while the MIC90 values of the antibiotics were determined as 1024 μg/mL, 64 μg/mL, and 16 μg/mL, respectively. An association between the phylogenetic groups, A and B1 with fluoroquinolone resistance was observed. These results point to the importance of awareness of the potential risk associated with empirical treatment with both the families of antibiotics.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26691475 PMCID: PMC4704613 DOI: 10.1590/S1517-838246420140880
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
PCR primers used to detect integrons or resistance genes and the expected sizes of amplicon.
| Target | Primer name | Primers (5′ → 3′) | Amplicon size (bp) | Reference |
|---|---|---|---|---|
|
| I5 (IntI1 F) | ACCGCCAACTTTCAGCACAT | 930 |
|
| I3 (IntI1 B) | GCGTTCGGTCAAGGTTCTGG | |||
|
| intI2 F | TTATTGCTGGGATTAGGC | 223 |
|
| intI2 R | ACGGCTACCCTCTGTTATC | |||
|
| intI3 F | TGTTCTTGTATCGGCAGGTG | 600 |
|
| intI3 R | AGTGGGTGGCGAATGAGTG | |||
|
| 341A | CGCCCACTCAAACAAACG | 468 |
|
| 341B | GAGGCTTTGGTGTAACCG | |||
|
| QnrAm-F | AGAGGATTTCTCACGCCAGG | 580 |
|
| QnrAm-R | TGCCAGGCACAGATCTTGAC | |||
|
| QnrBm-F | GGMATHGAAATTCGCCACTG | 264 |
|
| QnrBm-R | TTTGCYGYYCGCCAGTCGAA | |||
|
| qnrC-F | GGGTTGTACATTTATTGAATC | 307 |
|
| qnrC-R | TCCACTTTACGAGGTTCT | |||
|
| qnrD-F | CGAGATCAATTTACGGGGAATA | 581 |
|
| qnrD-R | AACAAGCTGAAGCGCCTG | |||
|
| QnrSm-F | GCAAGTTCATTGAACAGGGT | 428 |
|
| QnrSm-R | TCTAAACCGTCGAGTTCGGCG | |||
|
| QepA-GF | ACATCTACGGCTTCTTCGTCG | 502 |
|
| QepA-GR | AACTGCTTGAGCCCGTAGATC | |||
|
| AAC(6’)-F | CGATCTCATATCGTCGAGTG | 477 |
|
| AAC(6’)-R | TTAGGCATCACTGCGTGTTC | |||
|
| CITM F | TGGCCAGAACTGACAGGCAAA | 462 |
|
| CITM R | TTTCTCCTGAACGTGGCTGGC | |||
|
| DHAM F | AACTTTCACAGGTGTGCTGGGT | 405 |
|
| DHAM R | CCGTACGCATACTGGCTTTGC |
Antibiotic susceptibility profile of 71 studied isolates.
| Species | AMP | Number of resistant isolates (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| AMS | CTN | CTX | CAZ | GEN | CIP | NIT | TMS | ||
|
| 42 | 15 | 13 | 1 | 1 | 7 | 13 | 2 | 20 |
|
| 6 | 3 | 3 | 0 | 0 | 3 | 4 | 4 | 3 |
|
| 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 |
| Total (n = 71) | 49 (69%) | 18 (25%) | 16 (22%) | 1 (1.4%) | 1 (1.4%) | 10 (14%) | 18 (25%) | 8 (11%) | 24 (33%) |
AMP: ampicillin, AMS: ampicillin/sulbactam, CTN: cephalothin, CTX: cefotaxime, CAZ: ceftazidime, GEN: gentamicin, CIP: ciprofloxacin, NIT: nitrofurantoin, TMS: trimethoprim/sulfamethoxazole.